Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,022 INR | +0.57% | -3.68% | +19.62% |
Sales 2024 * | 121B 1.45B | Sales 2025 * | 140B 1.68B | Capitalization | 287B 3.43B |
---|---|---|---|---|---|
Net income 2024 * | 33.36B 400M | Net income 2025 * | 11.13B 133M | EV / Sales 2024 * | 2.52 x |
Net Debt 2024 * | 19.84B 238M | Net cash position 2025 * | 3.08B 36.9M | EV / Sales 2025 * | 2.02 x |
P/E ratio 2024 * |
40.1
x | P/E ratio 2025 * |
23.6
x | Employees | 15,556 |
Yield 2024 * |
0.23% | Yield 2025 * |
0.28% | Free-Float | 49.03% |
Latest transcript on Glenmark Pharmaceuticals Limited
1 day | +0.91% | ||
1 week | -3.35% | ||
Current month | -3.05% | ||
1 month | -1.36% | ||
3 months | +19.39% | ||
6 months | +30.42% | ||
Current year | +20.03% |
Managers | Title | Age | Since |
---|---|---|---|
Founder | - | - | |
Chief Executive Officer | 54 | 98-10-11 | |
Ulhas Dhuppad
PSD | President | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 59 | 20-08-13 | |
Cherylann Pinto
BRD | Director/Board Member | 56 | 99-10-05 |
Chief Executive Officer | 54 | 98-10-11 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.02% | 4 M€ | -4.41% | - | |
0.01% | 0 M€ | +3.30% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-08 | 1,022 | +0.57% | 213 896 |
24-05-07 | 1,016 | -2.39% | 560,484 |
24-05-06 | 1,041 | -1.20% | 414,896 |
24-05-03 | 1,053 | -0.68% | 845,271 |
24-05-02 | 1,060 | +0.31% | 324,107 |
Delayed Quote NSE India S.E., May 08, 2024 at 03:21 am EDT
More quotesEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+20.03% | 3.43B | |
+20.47% | 43.57B | |
+20.70% | 22.7B | |
+15.78% | 14.32B | |
+11.61% | 13.42B | |
+45.14% | 11.83B | |
-8.84% | 6.98B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+12.33% | 5.51B |
- Stock Market
- Equities
- GLENMARK Stock